来自MSN20 天
This California-Based Biotech Found Massive Success Following DSMB Approval
A California-based biotech company is turning heads during Tuesday’s session after the company announced its phase 2b COVID-19 trial received Independent Data Safety Monitoring Board (DSMB ...
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
SFGate21 天
Bay Area biotech firm CytomX, once worth $2.3 billion, lays off 40% of staff
CytomX Therapeutics, a once high-flying biotech ... The company announced its layoff round on Jan. 6, in a filing with the Securities and Exchange Commission and in a WARN notice to California.
The Globe and Mail2 个月
California-Based Biotech Rallies Strongly Following $558.4M Divestiture
A California-based biotech company found a tremendous amount of success on Tuesday following the company announcing an agreement to divest its Udenyca franchise for $558.4 million, according to a ...
The Business Journals21 天
California biotech lobbying group cuts staff ahead of leadership change
1 as president and CEO of the biotech advocacy group. Biocom California — one of two major ... That has forced companies to cut jobs, shelve drug-development programs, roll back real estate ...